sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó

ǰÑÔ

´¹ÌåÁö(pituitary tumor)ÊÇÒ»ÖÖ³£¼ûµÄ­ÄÚÖ×Áö£¬Ô¼Õ¼Â­ÄÚÖ×ÁöµÄ10£¥~15£¥ ¡£´¹Ìå¿É·Ö³É´¹ÌåǰҶ£¨ÏÙ´¹Ì壩ºÍ´¹ÌåºóÒ¶£¨Éñ¾­´¹Ì壩Á½´ó²¿·Ö ¡£´¹ÌåǰҶϸ°ûÉøÍ¸ÃÚÈéËØ(prolactin,PRL)¡¢´ÙÉöÉÏÏÙÆ¤Öʼ¤ËØ(adrenocorticotropic hormone,ACTH)¡¢ÂÑÅݴ̼¤ËØ(follicle stimulating hormone,FSH)ºÍÐþɫϸ°û´Ì¼¤ËØ(melanocyte stimulating hormone,MSH)µÈ ¡£Éñ¾­´¹Ìå×Ô¼º²»ÖÆÔì¼¤ËØ£¬¶øÊÇÆðÒ»¸ö¿ÍÕ»µÄ×÷Óà ¡£ÏÂÇðÄÔµÄÊÓÉϺ˺ÍÊÒÅÔºËÌìÉúµÄ¿¹ÀûÄò¼¤Ëغʹ߲úËØ£¬Í¨¹ýÏÂÇðÄÔÓë´¹ÌåÖ®¼äµÄÉñ¾­ÏËά±»Ë͵½Éñ¾­´¹ÌåÖü´æÆðÀ´£¬µ±ÉíÌåÐèҪʱ¾ÍÊͷŵ½ÑªÒºÖÐ ¡£

´¹ÌåÁöÒÔǰҶµÄÏÙÁöÕ¼´ó´ó¶¼£¬À´×ÔºóÒ¶ÕßÉÙ¼û ¡£´¹ÌåÁöµÄÖ¢×´ÌåÕ÷Ö÷ÒªÊÇÓÉÓÚÖ×ÁöµÄ¾Ö²¿Õ¥È¡£¬»ò¼¤ËØÉøÍ¸¹ý¶à£¬»òÒòÖÎÁÆÒýÆðµÄ¼¤ËØÉøÍ¸È±·¦¶øÌåÏÖ³öһϵÁеÄÁÙ´²ÌåÏÖ ¡£Ö×Áöեȡ´¹ÌåÖÜΧ×éÖ¯ÌåÏÖΪһÁ¬ÐÔÍ·Í´£¬ÊÓ½»Ö¯¼°ÊÓÉñ¾­ÊøÕ¥È¡Ö¢£¬·ºÆðÊÓÁ¦¼õÍË¡¢ÊÓҰȱËðºÍÑ۵׸ıäµÈ ¡£¼¤ËØÉøÍ¸Òì³£ÌåÏÖΪ¹¦Ð§ÐÔÖ×Áöϸ°ûÉøÍ¸¹ý¶à¼¤ËØ£¬ÈçÉú³¤¼¤Ëعý¶àÒýÆðÖ«¶Ë·Ê´óÖ¢£¬»òÎÞ¹¦Ð§ÐÔÖ×ÁöÔö´ó£¬ÆÆËðÕý³£´¹Ìå×é֯ʱÒýÆð¼¤ËØÉøÍ¸¹ýÉÙ£¬Èç´ÙÐÔÏÙ¼¤ËØÉøÍ¸ïÔÌ­¶ø±Õ¾­¡¢²»Óý»òÑôήµÈ ¡£

´¹ÌåÁö¶¯ÎïÄ£×Ó¿É·ÖΪÓÕ·¢ÐÔ´¹ÌåÁöÄ£×Ó¡¢×Ô¾õÐÔ´¹ÌåÁöÄ£×Ó¡¢ÒÆÖ²ÐÔ´¹ÌåÁöÄ£×ÓÒÔ¼°»ùÒòÐÞÊδ¹ÌåÁöÄ£×ÓËÄÀà ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

°´±»ÒÆÖ²´¹ÌåÁö×éÖ¯µÄȪԴ¿É½«´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó·ÖΪ×Ô¾õÐÔ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó¡¢ÓÕ·¢ÐÔ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×ÓºÍÈË´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó ¡£°´ÒÆÖ²µÄ²¿Î»ÓÖ¿É·ÖΪƤÏÂÒÆÖ²¡¢ÉöÏ®ÄÚÒÆÖ²ºÍÄÔÄÚÒÆÖ²ÈýÖÖ ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ƾ֤ʵÑéÒªÇ󽫱»ÒÆÖ²´¹ÌåÁö×éÖ¯ÒÆÖ²µ½Æ¤Ï¡¢ÉöÄÒĤÄÚ»òÄÔÄÚ ¡£

¡¾Ä£×ÓÌØµã¡¿£º

±»ÒÆÖ²ÁöÊÇ×Ô¾õ±¬·¢µÄ£»Ö×ÁöÔÚÒÆÖ²µÄµÚÒ»´ú´óÊóÌåÄÚÉú³¤»ºÂý£¬ÌåÏÖ³öÁ¼ÐÔÌØÕ÷£»Ö×ÁöÖ»ÉøÍ¸PRL£»ºÍÈËÀàPRLÁöÓÐÏàͬµÄ×éÖ¯ÐÎÌ¬Ñ§ÌØÕ÷£»¶Ô´Æ¼¤ËØÃô¸Ð£»PRLµÄÉøÍ¸ºÍÖ×ÁöµÄÉú³¤Êܶà°Í°·ÊÜÌ弤¶¯¼ÁµÄÒÖÖÆ ¡£×Ô¾õÐÔ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×ÓսʤÁË×Ô¾õÐÔ´¹ÌåÁö¶¯ÎïÄ£×ÓºÄ Ê±³¤¡¢ÆÆ·Ñ´ó¡¢Ö×ÁöÌå»ýС¡¢Î»ÖÃÉîµÈȱ·¦Ö®´¦ ¡£

ÓÃF344´óÊó½¨ÉèµÄ´Æ¼¤ËØÓÕ·¢ÐÔ´¹ÌåÁöÄ£×Ó¾ÙÐÐÒÆÖ²£¬ÒÆÖ²ÊÜÌåÎÞÐè´Æ¼¤ËØ´¦Öóͷ££¬ÈÝÒ×½¨Éè ¡£Ö×ÁöÉú³¤Ñ¸ËÙ£¬¿ÉÌṩ¸»×ãµÄÁö×éÖ¯ÓÃÓÚÉú»¯Ñо¿£¬²¢Çҿɽ¨ÉèÁöϸ°ûϵ ¡£

ÓÃÈËÀà´¹ÌåÏÙÁöÒÆÖ²µ½ÂãÊóƤÏ¿ɼá³Ö¼¤ËصÄÉøÍ¸¹¦Ð§ ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

ÒÆÖ²ÐÔ´¹ÌåÁö¶¯ÎïÄ£×Ó¿ÉÓö¯Îï×Ô¾õÐÔ´¹ÌåÁöÖÐÊèÉ¢³öÀ´µÄϸ°û£¬¾­ÓÉÔ­´ú×÷ÓýºóÒÆÖ²µ½Í¬ÖÖ¶¯ÎïµÄÌåÄÚ£¬»òÓÃÈË´¹ÌåÁöϸ°ûÒÆÖ²µ½Tϸ°ûÃâÒßȱÏݶ¯ÎïÉíÉÏ£¬½¨É趯ÎïÄ£×Ó£¬¿ÉÓÃÓÚп¹Ö×ÁöÒ©ÎïµÄɸѡºÍҩЧѧÑо¿ ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅÃÍ£¬ÕÅÇïÉú£¬ÁÖºãÖÝ£¬µÈ. ÒÒÏ©´Æ·ÓÓÕµ¼µÄ´óÊó´¹ÌåÁöÄ£×ӵĽ¨É裮Öйú²¡ÀíÐÄÀíÔÓÖ¾£¬2012, 28 (8): 1532-1536

2.Helseth A, Siegal GP, Haug E, et al Transgenic mice that develop pituitary tumors. A model for Cushing's disease£®Am J Pathol, 1992, 140 (5):1071-1080

3.Cristina C, Garc í a-Tornad ú I, D í az-Torga G, et al.Doparninergic 02 receptor knockout mouse: an animal model of prolactinoma. Front Horm Res, 2006, 35: 50-63

4.Ishii J, Kawakami Y. Recent progress in experimental pituitary tumors in various animals. Nihon Rinsho, 1993, 51 (10):2580-2584

5.Fedele M, Battista S, Kenyon L, et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene,2002,21 (20):3190-3198

6.Pernasetti F, Spacly TJ, Hall SB,et al. Pituitary turnorigenesi targeted by the ovine follicle-stimulating hormone beta­subunit gene regulatory region in transgenic mice. Mol Cell Endocrinol, 2003,203 (1-2): 169-183

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó
´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó

ǰÑÔ

´¹ÌåÁö(pituitary tumor)ÊÇÒ»ÖÖ³£¼ûµÄ­ÄÚÖ×Áö£¬Ô¼Õ¼Â­ÄÚÖ×ÁöµÄ10£¥~15£¥ ¡£´¹Ìå¿É·Ö³É´¹ÌåǰҶ£¨ÏÙ´¹Ì壩ºÍ´¹ÌåºóÒ¶£¨Éñ¾­´¹Ì壩Á½´ó²¿·Ö ¡£´¹ÌåǰҶϸ°ûÉøÍ¸ÃÚÈéËØ(prolactin,PRL)¡¢´ÙÉöÉÏÏÙÆ¤Öʼ¤ËØ(adrenocorticotropic hormone,ACTH)¡¢ÂÑÅݴ̼¤ËØ(follicle stimulating hormone,FSH)ºÍÐþɫϸ°û´Ì¼¤ËØ(melanocyte stimulating hormone,MSH)µÈ ¡£Éñ¾­´¹Ìå×Ô¼º²»ÖÆÔì¼¤ËØ£¬¶øÊÇÆðÒ»¸ö¿ÍÕ»µÄ×÷Óà ¡£ÏÂÇðÄÔµÄÊÓÉϺ˺ÍÊÒÅÔºËÌìÉúµÄ¿¹ÀûÄò¼¤Ëغʹ߲úËØ£¬Í¨¹ýÏÂÇðÄÔÓë´¹ÌåÖ®¼äµÄÉñ¾­ÏËά±»Ë͵½Éñ¾­´¹ÌåÖü´æÆðÀ´£¬µ±ÉíÌåÐèҪʱ¾ÍÊͷŵ½ÑªÒºÖÐ ¡£

´¹ÌåÁöÒÔǰҶµÄÏÙÁöÕ¼´ó´ó¶¼£¬À´×ÔºóÒ¶ÕßÉÙ¼û ¡£´¹ÌåÁöµÄÖ¢×´ÌåÕ÷Ö÷ÒªÊÇÓÉÓÚÖ×ÁöµÄ¾Ö²¿Õ¥È¡£¬»ò¼¤ËØÉøÍ¸¹ý¶à£¬»òÒòÖÎÁÆÒýÆðµÄ¼¤ËØÉøÍ¸È±·¦¶øÌåÏÖ³öһϵÁеÄÁÙ´²ÌåÏÖ ¡£Ö×Áöեȡ´¹ÌåÖÜΧ×éÖ¯ÌåÏÖΪһÁ¬ÐÔÍ·Í´£¬ÊÓ½»Ö¯¼°ÊÓÉñ¾­ÊøÕ¥È¡Ö¢£¬·ºÆðÊÓÁ¦¼õÍË¡¢ÊÓҰȱËðºÍÑ۵׸ıäµÈ ¡£¼¤ËØÉøÍ¸Òì³£ÌåÏÖΪ¹¦Ð§ÐÔÖ×Áöϸ°ûÉøÍ¸¹ý¶à¼¤ËØ£¬ÈçÉú³¤¼¤Ëعý¶àÒýÆðÖ«¶Ë·Ê´óÖ¢£¬»òÎÞ¹¦Ð§ÐÔÖ×ÁöÔö´ó£¬ÆÆËðÕý³£´¹Ìå×é֯ʱÒýÆð¼¤ËØÉøÍ¸¹ýÉÙ£¬Èç´ÙÐÔÏÙ¼¤ËØÉøÍ¸ïÔÌ­¶ø±Õ¾­¡¢²»Óý»òÑôήµÈ ¡£

´¹ÌåÁö¶¯ÎïÄ£×Ó¿É·ÖΪÓÕ·¢ÐÔ´¹ÌåÁöÄ£×Ó¡¢×Ô¾õÐÔ´¹ÌåÁöÄ£×Ó¡¢ÒÆÖ²ÐÔ´¹ÌåÁöÄ£×ÓÒÔ¼°»ùÒòÐÞÊδ¹ÌåÁöÄ£×ÓËÄÀà ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

°´±»ÒÆÖ²´¹ÌåÁö×éÖ¯µÄȪԴ¿É½«´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó·ÖΪ×Ô¾õÐÔ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó¡¢ÓÕ·¢ÐÔ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×ÓºÍÈË´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×Ó ¡£°´ÒÆÖ²µÄ²¿Î»ÓÖ¿É·ÖΪƤÏÂÒÆÖ²¡¢ÉöÏ®ÄÚÒÆÖ²ºÍÄÔÄÚÒÆÖ²ÈýÖÖ ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ƾ֤ʵÑéÒªÇ󽫱»ÒÆÖ²´¹ÌåÁö×éÖ¯ÒÆÖ²µ½Æ¤Ï¡¢ÉöÄÒĤÄÚ»òÄÔÄÚ ¡£

¡¾Ä£×ÓÌØµã¡¿£º

±»ÒÆÖ²ÁöÊÇ×Ô¾õ±¬·¢µÄ£»Ö×ÁöÔÚÒÆÖ²µÄµÚÒ»´ú´óÊóÌåÄÚÉú³¤»ºÂý£¬ÌåÏÖ³öÁ¼ÐÔÌØÕ÷£»Ö×ÁöÖ»ÉøÍ¸PRL£»ºÍÈËÀàPRLÁöÓÐÏàͬµÄ×éÖ¯ÐÎÌ¬Ñ§ÌØÕ÷£»¶Ô´Æ¼¤ËØÃô¸Ð£»PRLµÄÉøÍ¸ºÍÖ×ÁöµÄÉú³¤Êܶà°Í°·ÊÜÌ弤¶¯¼ÁµÄÒÖÖÆ ¡£×Ô¾õÐÔ´¹ÌåÁöÒÆÖ²ÐÔ¶¯ÎïÄ£×ÓսʤÁË×Ô¾õÐÔ´¹ÌåÁö¶¯ÎïÄ£×ÓºÄ Ê±³¤¡¢ÆÆ·Ñ´ó¡¢Ö×ÁöÌå»ýС¡¢Î»ÖÃÉîµÈȱ·¦Ö®´¦ ¡£

ÓÃF344´óÊó½¨ÉèµÄ´Æ¼¤ËØÓÕ·¢ÐÔ´¹ÌåÁöÄ£×Ó¾ÙÐÐÒÆÖ²£¬ÒÆÖ²ÊÜÌåÎÞÐè´Æ¼¤ËØ´¦Öóͷ££¬ÈÝÒ×½¨Éè ¡£Ö×ÁöÉú³¤Ñ¸ËÙ£¬¿ÉÌṩ¸»×ãµÄÁö×éÖ¯ÓÃÓÚÉú»¯Ñо¿£¬²¢Çҿɽ¨ÉèÁöϸ°ûϵ ¡£

ÓÃÈËÀà´¹ÌåÏÙÁöÒÆÖ²µ½ÂãÊóƤÏ¿ɼá³Ö¼¤ËصÄÉøÍ¸¹¦Ð§ ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

ÒÆÖ²ÐÔ´¹ÌåÁö¶¯ÎïÄ£×Ó¿ÉÓö¯Îï×Ô¾õÐÔ´¹ÌåÁöÖÐÊèÉ¢³öÀ´µÄϸ°û£¬¾­ÓÉÔ­´ú×÷ÓýºóÒÆÖ²µ½Í¬ÖÖ¶¯ÎïµÄÌåÄÚ£¬»òÓÃÈË´¹ÌåÁöϸ°ûÒÆÖ²µ½Tϸ°ûÃâÒßȱÏݶ¯ÎïÉíÉÏ£¬½¨É趯ÎïÄ£×Ó£¬¿ÉÓÃÓÚп¹Ö×ÁöÒ©ÎïµÄɸѡºÍҩЧѧÑо¿ ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅÃÍ£¬ÕÅÇïÉú£¬ÁÖºãÖÝ£¬µÈ. ÒÒÏ©´Æ·ÓÓÕµ¼µÄ´óÊó´¹ÌåÁöÄ£×ӵĽ¨É裮Öйú²¡ÀíÐÄÀíÔÓÖ¾£¬2012, 28 (8): 1532-1536

2.Helseth A, Siegal GP, Haug E, et al Transgenic mice that develop pituitary tumors. A model for Cushing's disease£®Am J Pathol, 1992, 140 (5):1071-1080

3.Cristina C, Garc í a-Tornad ú I, D í az-Torga G, et al.Doparninergic 02 receptor knockout mouse: an animal model of prolactinoma. Front Horm Res, 2006, 35: 50-63

4.Ishii J, Kawakami Y. Recent progress in experimental pituitary tumors in various animals. Nihon Rinsho, 1993, 51 (10):2580-2584

5.Fedele M, Battista S, Kenyon L, et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene,2002,21 (20):3190-3198

6.Pernasetti F, Spacly TJ, Hall SB,et al. Pituitary turnorigenesi targeted by the ovine follicle-stimulating hormone beta­subunit gene regulatory region in transgenic mice. Mol Cell Endocrinol, 2003,203 (1-2): 169-183

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿